Ceftazidime and Swelling - a phase IV clinical study of FDA data

Summary:

Swelling is reported as a side effect among people who take Ceftazidime (ceftazidime), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Fungal infection.

The phase IV clinical study analyzes which people have Swelling when taking Ceftazidime. It is created by eHealthMe based on reports of 10,307 people who have side effects when taking Ceftazidime from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Swelling?

Swelling is found to be associated with 2,300 drugs and 2,891 conditions by eHealthMe. Check the latest studies of Swelling.

On Jul, 10, 2026

10,307 people reported to have side effects when taking Ceftazidime.
Among them, 17 people (0.16%) have Swelling.

Among these 17 people:

How long have people been on Ceftazidime when they have Swelling? *

What is the gender of people who have Swelling when taking Ceftazidime? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Swelling when taking Ceftazidime? *

What are other drugs people take besides Ceftazidime? *

What are other side effects people have besides Swelling? *

Rashes (redness): 9 people, 52.94%
Fever: 8 people, 47.06%
Chest Pain: 7 people, 41.18%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 29.41%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 29.41%
Pain In Extremity: 5 people, 29.41%
Urinary Tract Infection: 4 people, 23.53%
Pneumonia: 4 people, 23.53%
Thrombocytopenia (decrease of platelets in blood): 4 people, 23.53%
Osteonecrosis Of Jaw (death of bone of jaw): 4 people, 23.53%

What are the existing conditions these people have? *

Pneumonia: 2 people, 11.76%
Fungal Infection: 2 people, 11.76%
Skin Ulcer: 1 person, 5.88%
Rashes (redness): 1 person, 5.88%
Nausea (feeling of having an urge to vomit): 1 person, 5.88%
Metastases To Bone (cancer spreads to bone): 1 person, 5.88%
Infection: 1 person, 5.88%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 5.88%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 5.88%
Enterobacter Infection (infection caused by bacteria of the family enterobacteriaceae): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and have Swelling?

- Check whether Swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftazidime:

Ceftazidime (10,327 reports)

Swelling treatments and more:

Swelling (115,742 reports)

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling:

Swelling (2,300 drugs)

Browse all the conditions that are associated with Swelling:

Swelling (2,891 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Ceftazidime) and Ceftazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.